“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals”. 2022. Journal of Pharmaceutical Negative Results, November, 921-29. https://doi.org/10.47750/pnr.2022.13.S09.110.